Scientists at the University of California San Diego are hard at work on new genetic technologies intended for use in curbing mosquito populations, fighting the spread of malaria and mitigating the hazards associated with the deployment of gene-editing systems in the wild.
Mutations that lead to muscle atrophy can be repaired with the gene editor CRISPR-Cas9. A team led by ECRC researcher Helena Escobar has now introduced the tool into human muscle stem cells for the first time using mRNA, thus discovering a method suitable for therapeutic applications.
DUBLIN, March 1, 2022 /PRNewswire/ ERS Genomics announced today that the U.S. Patent and Trademark Office's Patent Trial and Appeal Board ("PTAB") confirmed that its decision regarding